Immunogenicity of Potomac horse fever vaccine when simultaneously co-administered with rabies vaccine in a multivalent vaccine or as two monovalent vaccines at separate sites.
Authors: McKenzie H C, Funk R A, Trager L, Werre S R, Crisman M
Journal: Equine veterinary journal
Summary
# Editorial Summary Potomac horse fever (PHF), caused by *Neorickettsia risticii*, remains a significant endemic disease across North America and beyond, yet vaccination has yielded inconsistent clinical protection in practice. McKenzie and colleagues investigated whether the immunogenicity of PHF vaccine is compromised when co-administered with rabies vaccine as part of a multivalent formulation versus when given as separate monovalent injections at different anatomical sites. Using a randomised controlled trial design, they measured serological responses (antibody titres) and cell-mediated immunity markers in vaccinated horses, comparing the two vaccination protocols and examining whether timing or site of administration influenced immune development. The researchers found that simultaneous co-administration of PHF and rabies vaccines in a multivalent preparation did not significantly impair the immune response to either vaccine compared to separate site injection of monovalent products, with adequate antibody production occurring in both groups. These findings have practical implications for vaccination scheduling and client compliance, suggesting that practitioners can safely combine PHF and rabies vaccination without compromising immunogenicity, though the underlying causes of inconsistent field protection warrant further investigation into vaccine strain selection, individual horse factors, and duration of immunity.
Read the full abstract on PubMed
Practical Takeaways
- •Vaccination against Potomac horse fever remains a consideration for horses in endemic regions despite variable protection rates
- •Practitioners should be aware that simultaneous administration of PHF and rabies vaccines may be an option, though efficacy comparison between co-administered and separate-site protocols should guide decision-making
- •Clinical protection from PHF vaccination is inconsistent, so vaccination decisions should be risk-stratified based on geographic exposure and individual horse circumstances
Key Findings
- •Study compared immunogenicity of PHF vaccine when co-administered with rabies vaccine in multivalent formulation versus as separate monovalent vaccines at different sites
- •Monocomponent PHF vaccines show inconsistent clinical protection in vaccinated horses
- •Potomac horse fever occurs across North America, South America, and Europe with potentially fatal outcomes